News

Filter

Current filters:

Envoy Therapeutics

Another acquisition for Takeda, Envoy Therapeutics for up to $140 million

07-11-2012

Takeda Pharmaceutical (TYO: 4502), Japan's largest drugmaker, has clearly not quenched its thirst for…

Envoy TherapeuticsMergers & AcquisitionsNeurologicalPharmaceuticalTakeda Pharmaceuticals

Takeda in schizophrenia research alliance with Envoy Thera

11-10-2010

Japan’s largest drugmaker Takeda Pharmaceutical (TSE:4502) has formed a three-year research alliance…

Envoy TherapeuticsLicensingNeurologicalPharmaceuticalResearchTakeda Pharmaceuticals

COMPANY SPOTLIGHT

Menarini

Back to top